New therapy for mild cognitive impairment
Part of Brain & nervous system clinical trials.
This trial tests a new combination of treatments for people with mild cognitive impairment (MCI). It aims to improve memory and thinking skills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 65 and 85 years
- At least 1 year of education
- Normal memory and thinking for your age and education level
- Able to see and hear well enough to complete the assessments
- No major depression, schizophrenia, or other brain disorders
- No severe physical illnesses like advanced heart disease, stroke, cancer, or uncontrolled diabetes
- No autoimmune diseases like rheumatoid arthritis or lupus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a gentle electrical brain stimulation technique called tACS can improve working memory in people with mild cognitive impairment (MCI). If you have MCI due to early Alzheimer's, this study may help find new ways to boost memory.
This trial tests whether daily scent training can help improve memory and thinking in people with mild cognitive impairment (MCI), a condition that is more than normal aging but not dementia. You would smell different odors at home and track your progress.
This trial tests whether transcranial magnetic stimulation (a noninvasive brain stimulation technique) can help people with mild cognitive impairment (MCI). You and a close contact, like a spouse or friend, will both take part in the study over several sessions.
This trial tests a program that combines mental exercises with stress management techniques for adults who have mild memory or thinking problems and feel stressed. It aims to improve quality of life and slow down memory decline.
This trial tests whether a gentle, non-invasive brain stimulation (transcranial alternating current) can improve memory and thinking in people with early Alzheimer's or mild memory problems. It involves regular sessions of stimulation and check-ups over several months.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
Hear when a new MCI-AD, Early Stage Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.